Law360 (November 27, 2019, 10:11 AM EST) — While the U.S. Food and Drug Administration cautiously builds a science-backed framework to regulate the sale of CBD products, states and localities are stepping in to fill the gap. But experts say this patchwork approach is creating more anxiety than relief.
Companies that sell CBD products face contradictory regulations within the same states and across borders, and even lawyers are struggling to keep up with who can sell what products where and how products can be labeled and transported, attorneys said.
“We’ve created both a 50-state survey and a color-coded map so that we know what’s what. That work product is…